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This situation has led contributors to the Manual of Clinical Microbiology to state that the majority of the genomic species cannot be reliably distinguished by phenotypic tests. 5 Despite that, and because of the difficulties in differentiating the isolates according to their phenotypic characteristics, the term Acinetobacter calcoaceticus-Acinetobacter baumannii complex is often used. It is important to note, and this may be a limitation of the studies we comment on in this editorial, that in 3 of the 4 studies, 6 " 9 species identification was performed using phenotypic methods only, and the isolates were named either A. baumannii or A. baumannii-calcoaceticus. In the study in this issue of the journal by Griffith et al., 8 ribotyping, which could have been used to identify the isolates, was used to compare the isolates but not to identify them, and the isolates were also classified as A. baumanniicalcoaceticus.
One of the main concerns about A. baumannii is a characteristic that makes it a major threat to public health, namely, its remarkable ability to rapidly develop antibiotic resistance, mostly by acquisition of gene clusters carried by plasmids, 10 transposons, 11 or integrons, 12 ' 13 sometimes arranged in resistance islands within the genome.
14 This phenomenon led to multidrug resistance in this species within a few decades. 15 With the emergence of increasingly resistant strains, the management of A. baumannii infection has become a public health problem in many countries. To date, some strains of A. baumannii have become resistant to almost all currently available antibacterial agents, including carbapenems, which were once considered the drug of choice for treatment of A. baumannii infection. 1617 In this issue, Peleg et al. 9 describe the frightening emergence of carbapenem resistance in A. baumannii isolates over a 3-year period in an Australian hospital, significantly linked to an increased used of meropenem. They demonstrated, by pulsed-field gel electrophoresis, the clonal origin of these multidrug-resistant strains, but they failed to identify the mechanism associated with carbapenem resistance. The latter point is of particular interest, because Peleg et al. 9 screened strains for the presence of the genes for carbapenemhydrolyzing /3-lactamases most commonly found in other countries. However, although Peleg et al. 9 suggested that there may be a nonenzymatic mechanism of resistance or a new /3-lactamase, they did not search all currently described genes coding for carbapenem-hydrolyzing ^-lactamases. 18, 19 The identification of the mechanism involved in carbapenem resistance in this clonal population of A, baumannii should warrant further investigation to determine whether the bacterium has acquired a resistance gene that is spreading around the world or a gene "made in Australia." Finally, this article by Peleg et al. 9 emphasizes the risk of misuse of antibiotics, because of the extremely rapid emergence of antibiotic resistance in A. baumannii, and the consequent need for strict rules for prescription of carbapenems.
In addition to its propensity to acquire antibiotic resistance, A. baumannii is feared for its ability to cause outbreaks of disease in healthcare facilities. 20 Such outbreaks may take particular forms, such as those that involve multiple facilities. 13, 21 In France, the AYE strain, which produces an extended-spectrum /3-lactamase, spread throughout 54 healthcare facilities in 8 administrative regions during an 11-month period. 13 In their study, Fillaux et al. 6 used pulsed-field gel electrophoresis to compare 1,277 A. baumannii strains, including 148 mul-tidrug-resistant strains, isolated from 2000 to 2003 in a French hospital. The study was conducted retrospectively to evaluate the epidemiology of A. baumannii in their hospital setting. However, although Fillaux et al. 6 identified an extended-spectrum |8-lactamase-producing clone that was endemic during 2001-2003, they did not determine whether this strain was related to the AYE strain. In addition, although they described a decrease in antibiotic susceptibility over the study period, they did not correlate it with the level of antibiotic consumption in the hospital. Nonetheless, the study demonstrated the co-occurrence of several multidrug-resistant strains, with seasonal variations in the strains identified during the study years.
From January 1, 2002, to August 31, 2004, A. baumannii grew from the blood of 102 patients hospitalized at military medical facilities treating service members injured in Afghanistan and the Iraq/Kuwait region. 22 The sources of A. baumannii that led to the infections were not found, but, during the Vietnam War, A. baumannii was the most common gramnegative bacillus recovered from traumatic injuries to extremities. 23 In this issue, Griffith et al. 8 report on their search for the source and/or reservoir of these infections. They performed a prospective study in a population of healthy, nondeployed US Army soldiers. The results are interesting, even though the mystery of the source and/or reservoir of the strains infecting injured service members has not been found, because they confirm that skin colonization with A. baumannii-calcoaceticus in healthy individuals is common and may serve as a source for infection. In addition, the organisms were found on body sites, such as the forehead and the feet, usually not screened during epidemiologic studies.
In conclusion, A. baumannii remains a puzzling bacterium that requires additional studies to solve all its mysteries.
